|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [679]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [679]
Dougherty, D. D., Rauch, S. L., & Jenike, M. A. (2002). Pharmacological treatments for obsessive compulsive disorder. In P. E. Nathan & J. M. Gorman (Eds.), A guide to treatments that work (2nd ed.) London: Oxford University Press.
Dummit, E. S., Klein, R. G., Tancer, N. K., Asche, B., Martin, J., & Fairbanks, J. A. (1997). Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 653–660.
Eaves, L. J., Eysenck, H. J., & Martin M. (1989). Genes, culture and personality; An empirical approach. New York: Academic Press.
Eaves, L. J., Silberg, J. L., Maes, H. H., Simonoff, E., Pickles, A., Rutter, M., et al. (1997). Genetics and developmental psychopathology: The main effects of genes and environment on behavioral problems in the Virginia Twin Study of adolescent behavior development. Journal of Child Psychology and Psychiatry and Allied Disciplines, 38, 965–980.
Echeburua, E., de Corral, P., Zubizarreta, I., & Sarsua, B. (1997). Psychological treatment of chronic posttraumatic stress disorder in victims of sexual aggression. Behavior Modification, 21, 433–456.
Emslie, G. J., Rush, A. J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1037.
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., et al. (1998). Neurogenesis in the adult human hippocampus. Nature Medicine, 4, 1313–1317.
Fairbanks, J. M., Pine, D. S., Tancer, N. K., Dummit E. S., III, Kentgen, L. M., Asche, B. K., et al. (1997). Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 7, 17–29.
Famularo, R., Spivak, G., Bunshaft, D., & Berkson, J. (1988). Advisability of substance abuse testing in parents who severely maltreat their children: The issue of drug testing before the juvenile/family courts. Bulletin of the American Academy of Psychiatry and the Law, 16, 217–223.
Feigon, S., Waldman, I., Irwin, D., Levy, F., & Hay, D. A. (2001). Genetic and environmental influences on separation anxiety disorder symptoms and their moderation by age and sex. Behavior Genetics, 31, 403–411.
Findling, R. L., Reed, M. D., Myers, C., O'Riordan, M. A., Fiala, S., Branicky, L., et al. (1999). Paroxetine pharmacokinetics in depressed children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 952–959.
Fitzgerald, K. D., Stewart, C. M., Tawile, V., & Rosenberg, D. R. (1999). Risperidone augmentation of serotonin reuptake inhibitor treatment
end p.679
|
|
|
|